跳至主要内容
临床试验/NCT01123551
NCT01123551已完成3 期

Nebulized Morphine Versus Intravenous Morphine in the Management of Post Traumatic Pain in Emergency Department (ED)

University of Monastir1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2010年6月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
200
试验地点
1
主要终点
1. Resolution rate

研究概览

简要总结

In the emergency department, 60% of patients have an acute pain. Appropriate management of acute pain is a public health priority according to who recommendations. Nebulized morphine has been extensively studied in children but less well in adults.

It offers a non-invasive route for systemic drug delivery, more rapid and less invasive than intravenous (IV) method.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
8 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Post-traumatic pain with visual analog pain scale( VAPS) ≥ 50%
  • Age between 8 and 50 years.

排除标准

  • Glasgow coma scale (GCS)< 14,
  • Severe injury ,
  • Hypotension : blood systolic pressure < 90 mmhg,
  • Bradypnea < 12 cpm or SaO2< 90%,
  • Chronic pain treatment,
  • Aspirin or paracetamol treatment within 6 hours of emergency presentation,
  • Nasal trauma, rhinitis, nasal obstruction,
  • Incapacity to cooperate,
  • Opiate allergy,
  • Drug addiction,
  • Pregnancy, breast feeding,
  • Severe renal and liver failure and chronic obstructive pulmonary disease(COPD)

研究组 & 干预措施

Nebulized Morphine

Experimental

After randomization, patients will receive 10 mg of morphine (1ml) diluted in 4 ml normal saline and nebulized with 6 l/mn during 10 min. Nebulization will be repeated systematically 3 times every twenty minutes unless the patient pain was resolved (VAPS 30%). In addition, patients receive a bolus of IV placebo(5 ml normal saline . IV placebo (2 ml) will be repeated every 10 minutes if the objective of analgesia was not reached .

干预措施: nebulized morphine (Drug)

Nebulized Morphine

Experimental

After randomization, patients will receive 10 mg of morphine (1ml) diluted in 4 ml normal saline and nebulized with 6 l/mn during 10 min. Nebulization will be repeated systematically 3 times every twenty minutes unless the patient pain was resolved (VAPS 30%). In addition, patients receive a bolus of IV placebo(5 ml normal saline . IV placebo (2 ml) will be repeated every 10 minutes if the objective of analgesia was not reached .

干预措施: Intravenous morphine (Drug)

Intravenous morphine

Active Comparator

After randomization, patients will receive a bolus of 5 mg of IV morphine (5 ml. Then, 2mg of IV morphine (2ml) will be added every 10 minutes if the objective of analgesia was not reached (VAPS >30%). In addition, normal saline (5ml)is nebulized with 6 l/mn during 10 min and will be repeated systematically every 20 minutes unless the patient's pain was not resolved (VAPS >30%).

干预措施: Intravenous morphine (Drug)

结局指标

主要结局

1. Resolution rate

时间窗: one hour

resolution is defined as VAPS \<30%.

次要结局

  • Resolution time(one hour)
  • rate of side effects(one hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nouira

Professor

University of Monastir

研究点 (1)

Loading locations...

相似试验

Efficacy Study of Nebulized Morphine and Intravenous... | 临床试验